SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREC14A - Preliminary proxy statements, contested solicitations:
SEC Accession No. 0000921895-23-002271
Filing Date
2023-09-29
Accepted
2023-10-02 08:42:12
Documents
2

Document Format Files

Seq Description Document Type Size
1 prec14a13392004_09292023.htm PREC14A 261320
2 GRAPHIC image_001.jpg GRAPHIC 24070
  Complete submission text file 0000921895-23-002271.txt   296327
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Subject) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: PREC14A | Act: 34 | File No.: 000-50484 | Film No.: 231298028
SIC: 2834 Pharmaceutical Preparations

Mailing Address 16000 DALLAS PARKWAY SUITE 800 DALLAS TX 75248
Business Address 16000 DALLAS PARKWAY SUITE 800 DALLAS TX 75248 214.866.0202
Anson Funds Management LP (Filed by) CIK: 0001491072 (see all company filings)

IRS No.: 300134498 | State of Incorp.: TX | Fiscal Year End: 1231
Type: PREC14A